Dex-CSDH randomised, placebo-controlled trial of dexamethasone for chronic subdural haematoma: report of the internal pilot phase
暂无分享,去创建一个
M. Papadopoulos | E. Thelin | R. Piper | D. Nandi | H. Marcus | P. Hutchinson | A. Kolias | G. Barton | D. Bulters | A. Chari | P. Whitfield | G. Critchley | A. Belli | P. Brennan | C. Eglinton | L. Whitehead | S. Thomson | I. Anderson | J. Kandasamy | M. Zaben | D. Gatt | D. Georgieva | K. Yakoub | R. Gafoor | Y. Al-Tamimi | F. Hogg | M. J. Gallagher | N. Tzerakis | E. Edlmann | K. Hossain-Ibrahim | M. Kambafwile | L. Finlay | I. Coulter | O. Richards | A. Zolnourian | N. Gurusinghe | K. Badran | C. Turner | P. Bodkin | S. Bond | A. Wiggins | E. Toman | M. Vintu | Jash Patel | N. Suttner | A. Razak | Emanuel Cirstea | H. Soleiman | A. Wahba | R. Nannapaneni | N. Haliasos | D. Paraskevopoulos | B. Pantaleo | P. Holton | K. Owusu-Agyemang | C. Pringle | Sarah N. Dawson | D. Holliman | K. Caldwell | Monica Gherle | Phillip Kane | C. Davis-Wilkie | S. Tarantino | Ian Wilkinson | Masood Hussain | K. S. Manjunath Prasad | Khaled Ian Mathew J. Florence R. A. Catherine Adam Hamzah Badran Coulter Gallagher Hogg Pringle Raza | L. Ortiz-Ruiz de Gordoa
[1] S. Treweek,et al. Strategies to improve recruitment to randomised trials. , 2018, The Cochrane database of systematic reviews.
[2] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[3] P. Hutchinson,et al. The British Neurosurgical Trainee Research Collaborative: Five years on , 2017, Acta Neurochirurgica.
[4] A. Jamjoom,et al. Randomized controlled trials in neurosurgery: an observational analysis of trial discontinuation and publication outcome. , 2017, Journal of neurosurgery.
[5] P. Hutchinson,et al. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy , 2017, Journal of Neuroinflammation.
[6] M. Rogers,et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study , 2017, British Medical Journal.
[7] C. Gamble,et al. Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies , 2017, BMJ Open.
[8] Feiran Sun,et al. Risk factors for recurrence of chronic subdural hematoma after burr hole surgery: potential protective role of dexamethasone , 2017, British journal of neurosurgery.
[9] L. Marshman,et al. Long-term survival after chronic subdural haematoma , 2016, Journal of Clinical Neuroscience.
[10] P. Tugwell,et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials , 2016, British Medical Journal.
[11] T. Santarius,et al. Core Outcomes and Common Data Elements in Chronic Subdural Hematoma: A Systematic Review of the Literature Focusing on Reported Outcomes , 2016, Journal of neurotrauma.
[12] E. Matteson,et al. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review. , 2016, JAMA.
[13] S. Cottin,et al. A Pilot Placebo Controlled Randomized Trial of Dexamethasone for Chronic Subdural Hematoma , 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[14] D. Kondziolka,et al. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered? , 2016, Journal of neurosurgery.
[15] F. Barker. Editorial: Randomized clinical trials and neurosurgery. , 2016, Journal of neurosurgery.
[16] A. K. Thotakura,et al. Nonsurgical Treatment of Chronic Subdural Hematoma with Steroids. , 2015, World neurosurgery.
[17] M. Melbye,et al. Recurrence of Subdural Haematoma in a Population-Based Cohort – Risks and Predictive Factors , 2015, PloS one.
[18] W. Poon,et al. Steroid for chronic subdural hematoma? A prospective phase IIB pilot randomized controlled trial on the use of dexamethasone with surgical drainage for the reduction of recurrence with reoperation , 2015, Chinese Neurosurgical Journal.
[19] A. Brodbelt,et al. Glioblastoma in England: 2007-2011. , 2015, European journal of cancer.
[20] J. Wardle,et al. Sleep and nighttime energy consumption in early childhood: a population‐based cohort study , 2015, Pediatric obesity.
[21] J. Walters,et al. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. , 2014, The Cochrane database of systematic reviews.
[22] T. Santarius,et al. Chronic subdural haematoma: modern management and emerging therapies , 2014, Nature Reviews Neurology.
[23] W. Hitzl,et al. The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma – the DRESH study: straightforward study protocol for a randomized controlled trial , 2014, Trials.
[24] G. Rait,et al. Strategies to improve retention in randomised trials , 2013, The Cochrane database of systematic reviews.
[25] M. Aries,et al. Cerebral perfusion changes in chronic subdural hematoma. , 2013, Journal of neurotrauma.
[26] Gillian E. Caughey,et al. Comorbid Diabetes and COPD , 2013, Diabetes Care.
[27] J. Piercy,et al. Community consultation in emergency neurotrauma research: results from a pre-protocol survey , 2013, Acta Neurochirurgica.
[28] C. Dirven,et al. The role of corticosteroids in the management of chronic subdural hematoma: a systematic review , 2012, European journal of neurology.
[29] Geoff Watts,et al. Why the exclusion of older people from clinical research must stop , 2012, BMJ : British Medical Journal.
[30] Hester F. Lingsma,et al. Clinical Factors Associated With Outcome in Chronic Subdural Hematoma: A Retrospective Cohort Study of Patients on Preoperative Corticosteroid Therapy , 2012, Neurosurgery.
[31] L. Trinquart,et al. Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs , 2012, PloS one.
[32] J. Switzer,et al. Simplified Modified Rankin Scale Questionnaire: Reproducibility Over the Telephone and Validation With Quality of Life , 2011, Stroke.
[33] T. Santarius,et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial , 2009, The Lancet.
[34] J. Geddes,et al. What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.
[35] Jae-Min Kim,et al. Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma. , 2009, Surgical neurology.
[36] F. Erol,et al. The effectiveness of simple drainage technique in improvement of cerebral blood flow in patients with chronic subdural hemorrhage. , 2007, Turkish neurosurgery.
[37] S. Vondracek,et al. Is There an Optimal Corticosteroid Regimen for the Management of an Acute Exacerbation of Chronic Obstructive Pulmonary Disease? , 2006, Pharmacotherapy.
[38] K. Ogasawara,et al. Local elevation of the anti-inflammatory interleukin-10 in the pathogenesis of chronic subdural hematoma , 2006, Neurosurgical Review.
[39] M. Mcmurdo,et al. Including older people in clinical research , 2005, BMJ : British Medical Journal.
[40] H. Cohen,et al. Never too old? Age should not be a barrier to enrollment in cancer clinical trials. , 2005, The oncologist.
[41] W. Poon,et al. Non-surgical primary treatment of chronic subdural haematoma: Preliminary results of using dexamethasone , 2005, British journal of neurosurgery.
[42] P. Sandercock,et al. Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial , 2004, The Lancet.
[43] Kenneth F Schulz,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Exclusions before Randomisation Exclusions after Randomisation Sample Size Slippages in Randomised Trials: Exclusions and the Lost and Wayward , 2022 .
[44] S. Inao,et al. Relation between brain displacement and local cerebral blood flow in patients with chronic subdural haematoma , 2001, Journal of neurology, neurosurgery, and psychiatry.
[45] M. Y. Lee,et al. The Application of Transcranial Doppler Sonography in Patients with Chronic Subdural Haematoma , 1999, Acta Neurochirurgica.
[46] B. Rosen,et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. , 1999, Journal of neurosurgery.
[47] N. Black. CONSORT , 1996, The Lancet.
[48] W. van Putten,et al. Dose‐effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors , 1994, Neurology.
[49] H. Schouten,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.
[50] M. B. Bender,et al. Nonsurgical treatment of subdural hematomas. , 1974, Archives of neurology.
[51] The Lancet Psychiatry. Five years. , 2016, The lancet. Psychiatry.
[52] A. Preiss,et al. Impact of corticosteroid use on diabetes complications , 2013 .
[53] W. Stummer,et al. Cerebral perfusion changes in chronic subdural hematoma. , 2013, Journal of neurotrauma.
[54] Gillian,et al. Comorbid Diabetes and COPD Impact of corticosteroid use on diabetes complications , 2013 .
[55] M. Stanišić,et al. Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study , 2011, Acta Neurochirurgica.
[56] P. Delgado-López,et al. Dexamethasone treatment in chronic subdural haematoma. , 2009, Neurocirugia.
[57] J. Manson,et al. Prospective Study of , 2007 .
[58] J. Haselgrove,et al. Resorption of peritumoural oedema in cerebral gliomas during dexamethasone treatment evaluated by NMR relaxation time imaging , 2005, Acta Neurochirurgica.
[59] H. Herrmann,et al. The influence of dexamethasone on the blood-brain-barrier and water content in experimental brain oedema , 2005, Acta Neurochirurgica.
[60] J. Swieten. Interobserver Agreement for the Assessment of Handicap in Stroke Patients , 2005 .
[61] R. Delfini,et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. , 2004, Journal of neurosurgery.
[62] S. Hampson. Randomised, placebo-controlled trial , 2002 .
[63] F. Jensen,et al. Differences in Blood-Tumour-Barrier Leakage of Human Intracranial Tumours: Quantitative Monitoring of Vasogenic Oedema and its Response to Glucocorticoid Treatment , 1998, Acta Neurochirurgica.
[64] D. Long,et al. The Clinical Effects of a Synthetic Gluco-Corticoid used for Brain Edema in the Practice of Neurosurgery , 1972 .
[65] F. Barker. Randomized clinical trials and neurosurgery , 2022 .